Recent Posts

New Year holds promise for China IPOs after 2022 haul

  Bloomberg Chinese companies raised a record amount in initial public offerings (IPOs) at home this year, defying a global slump. And with the end of Covid Zero in sight, 2023 could be set for another strong showing. Listings in Shanghai, Shenzhen and the recently inaugurated Beijing exchange brought in $92 billion this year, according to data compiled by Bloomberg. ...

Read More »

Japan’s Takeda secures EU regulatory approval for its dengue vaccine

Bloomberg Takeda Pharmaceutical Co’s dengue vaccine was given the green light for use in Europe, making it the world’s second ever inoculation to be approved to fight the mosquito-borne disease that affects almost 400 million people a year. The European Commission approved the two-shot regimen, called Qdenga, for individuals four years of age and older, Takeda said. Takeda’s shots can ...

Read More »

GoTo slumps as executives fail to convince investors

  Bloomberg GoTo Group shares continued their plunge after executives failed to assuage investor concerns about the unprofitable Indonesian internet company’s prospects. The stock fell for a 15th straight day, hurt by the expiry of a lockup on its major shareholders’ stakes that freed them to reduce their holdings. Management held a meeting with investors in which it said it ...

Read More »
Send this to a friend